◆Molecular marker and kasp genotyping
◆Based on the second-generation sequencing technology, non-invasive prenatal screening, PGs / PGD, genetic disease detection, early tumor screening, tumor medication and prognosis monitoring, metabolic disease detection and pathogenic microorganism detection, etc.
◆Based on the fluorescence quantitative PCR technology, the items of blood screening, the detection of microbial infection, the early screening of tumor, the treatment of tumor drugs and the monitoring of prognosis, etc.
◆Detection of metabolic diseases based on mass spectrometry.
◆Gene detection based on second-generation sequencing technology, chip technology, first-generation sequencing, nucleic acid mass spectrometry, fluorescence quantitative PCR technology.
◆Screening of antibody drugs based on elase and htrf technology.